| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 1st Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $16,000 | |
| 2025 4th Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $16,000 | |
| 2025 3rd Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $16,000 | |
| 2025 2nd Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $16,000 | |
| 2025 1st Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $16,000 | |
| 2024 4th Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $15,500 | |
| 2024 3rd Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $15,500 | |
| 2024 2nd Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $15,500 | |
| 2024 1st Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $15,500 | |
| 2023 4th Quarter - Report |
THE HEALTH EQUITY STRATEGIES GROUP, LLC | TRAVERE THERAPEUTICS | $22,500 |